The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update-Reference-Cited by-同舟云学术

The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update

Published:2022-07-23 Issue:11 Volume:94 Page:5128-5148
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Jasim Saade Abdalkareem¹,Mahdi Roaa Salih²,Bokov Dmitry Olegovich³⁴,Najm Mazin A. A.⁵,Sobirova Guzal N.⁶,Bafoyeva Zarnigor O.⁶,Taifi Ahmed⁷,Alkadir Ola Kamal A.⁸,Mustafa Yasser Fakri⁹,Mirzaei Rasoul¹⁰^ORCID,Karampoor Sajad¹¹^ORCID

Affiliation:

1. Medical Laboratory Techniques Department Al‐Maarif University College Al‐Anbar‐Ramadi Iraq

2. Department of Pathology, College of Medicine University of Babylon Hilla Iraq

3. Institute of Pharmacy Sechenov First Moscow State Medical University Moscow Russian Federation

4. Laboratory of Food Chemistry Federal Research Center of Nutrition, Biotechnology and Food Safety Moscow Russian Federation

5. Pharmaceutical Chemistry Department, College of Pharmacy Al‐Ayen University Thi‐Qar Iraq

6. Department of Rehabilitation, Folk Medicine and Physical Education Tashkent Medical Academy Tashkent Uzbekistan

7. Al‐Manara College For Medical Sciences Iraq

8. Al‐Nisour University College Baghdad Iraq

9. Department of Pharmaceutical Chemistry, College of Pharmacy University of Mosul Mosul Iraq

10. Venom and Biotherapeutics Molecules Lab, Medical Biotechnology Department, Biotechnology Research Center Pasteur Institute of Iran Tehran Iran

11. Gastrointestinal and Liver Diseases Research Center Iran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28000

Reference262 articles.

1. The role of lovastatin in the attenuation of COVID-19

2. A possible pathogenic correlation between neutrophil elastase (NE) enzyme and inflammation in the pathogenesis of coronavirus disease 2019 (COVID-19)

3. The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

4. Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine

5. Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing of pyrazolotriazine derivatives as potential anti-SARS-CoV-2 agents: in vitro and in silico studies;BMC Chemistry;2024-07-16

2. Single-cell-resolved interspecies comparison shows a shared inflammatory axis and a dominant neutrophil-endothelial program in severe COVID-19;Cell Reports;2024-06

3. Hemostatic abnormalities for predicting and management of disease severity in COVID-19 affected patients: Review;Aspects of Molecular Medicine;2024-06

4. Conventional dendritic cell 2 links the genetic causal association from allergic asthma to COVID-19: a Mendelian randomization and transcriptomic study;Journal of Big Data;2024-02-04

5. Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds;International Immunopharmacology;2024-01